Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L5NZ
|
|||
Drug Name |
PMID25514969-Compound-Figure2-3
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Takeda Pharmaceutical Co. Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H23N3O2
|
|||
Canonical SMILES |
C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4
|
|||
InChI |
1S/C23H23N3O2/c27-22(20-7-4-12-25-21(20)19-8-13-24-14-9-19)26-15-10-23(28,11-16-26)17-18-5-2-1-3-6-18/h1-9,12-14,28H,10-11,15-17H2
|
|||
InChIKey |
XKUZMIUSBMCVPP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1429505-03-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cholesterol 24-hydroxylase (CYP46A1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Cholesterol 24-hydroxylase (CYP46A1) | Target's Patent Info | [1] | |
KEGG Pathway | Primary bile acid biosynthesis | |||
Pathwhiz Pathway | Bile Acid Biosynthesis | |||
Reactome | Endogenous sterols | |||
WikiPathways | Metapathway biotransformation | |||
Oxidation by Cytochrome P450 | ||||
Phase 1 - Functionalization of compounds | ||||
Bile acid and bile salt metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).Expert Opin Ther Pat. 2015 Mar;25(3):373-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.